Trial Profile
Open, Prospective, Controlled Case Series Documentation to Compare Intra-individually the Efficacy and Tolerance of Sericare® Versus Non-adhesive Wound Dressing Alone in Accelerating the Epithelialization of Skin Lesions of Patients With Epidermolysis Bullosa Hereditaria
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2018
Price :
$35
*
At a glance
- Drugs Birch triterpenes (Primary)
- Indications Epidermolysis bullosa
- Focus Therapeutic Use
- Sponsors Birken AG
- 12 Jun 2014 New trial record